Lactic acid bacteria as reducing and capping agent for the fast and efficient production of silver nanoparticles
- PMID: 19488750
- DOI: 10.1007/s00253-009-2032-6
Lactic acid bacteria as reducing and capping agent for the fast and efficient production of silver nanoparticles
Abstract
There is a growing demand for silver-based biocides, including both ionic silver forms and metallic nanosilver. The use of metallic nanosilver, typically chemically produced, faces challenges including particle agglomeration, high costs, and upscaling difficulties . Additionally, there exists a need for the development of a more eco-friendly production of nanosilver. In this study, Gram-positive and Gram-negative bacteria were utilized in the non-enzymatic production of silver nanoparticles via the interaction of silver ions and organic compounds present on the bacterial cell. Only lactic acid bacteria, Lactobacillus spp., Pediococcus pentosaceus, Enterococcus faecium, and Lactococcus garvieae, were able to reduce silver. The nanoparticles of the five best producing Lactobacillus spp. were examined more into detail with transmission electron microscopy. Particle localization inside the cell, the mean particle size, and size distribution were species dependent, with Lactobacillus fermentum having the smallest mean particle size of 11.2 nm, the most narrow size distribution, and most nanoparticles associated with the outside of the cells. Furthermore, influence of pH on the reduction process was investigated. With increasing pH, silver recovery increased as well as the reduction rate as indicated by UV-VIS analyses. This study demonstrated that Lactobacillus spp. can be used for a rapid and efficient production of silver nanoparticles.
Similar articles
-
Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use.Mol Pharm. 2009 Sep-Oct;6(5):1388-401. doi: 10.1021/mp900056g. Mol Pharm. 2009. PMID: 19473014
-
Silver nanocrystallites: biofabrication using Shewanella oneidensis, and an evaluation of their comparative toxicity on gram-negative and gram-positive bacteria.Environ Sci Technol. 2010 Jul 1;44(13):5210-5. doi: 10.1021/es903684r. Environ Sci Technol. 2010. PMID: 20509652
-
Silver-protein (core-shell) nanoparticle production using spent mushroom substrate.Langmuir. 2007 Jun 19;23(13):7113-7. doi: 10.1021/la063627p. Epub 2007 May 23. Langmuir. 2007. PMID: 17518485
-
Biologically produced nanosilver: current state and future perspectives.Biotechnol Bioeng. 2012 Oct;109(10):2422-36. doi: 10.1002/bit.24570. Epub 2012 Jun 27. Biotechnol Bioeng. 2012. PMID: 22674445 Review.
-
Silver nanoparticles as a new generation of antimicrobials.Biotechnol Adv. 2009 Jan-Feb;27(1):76-83. doi: 10.1016/j.biotechadv.2008.09.002. Epub 2008 Sep 30. Biotechnol Adv. 2009. PMID: 18854209 Review.
Cited by
-
Silver Nanoparticles Derived from Probiotic Lactobacillus casei-a Novel Approach for Combating Bacterial Infections and Cancer.Probiotics Antimicrob Proteins. 2023 Dec 12. doi: 10.1007/s12602-023-10201-3. Online ahead of print. Probiotics Antimicrob Proteins. 2023. PMID: 38085438
-
Optimization of the biosynthesis of silver nanoparticles using bacterial extracts and their antimicrobial potential.Biotechnol Rep (Amst). 2023 Oct 29;40:e00816. doi: 10.1016/j.btre.2023.e00816. eCollection 2023 Dec. Biotechnol Rep (Amst). 2023. PMID: 38020726 Free PMC article.
-
Novel green synthesis of silver nanoparticles mediated by Curcumae kwangsiensis for anti-lung cancer activities: a preclinical trial study.Arch Med Sci. 2021 Mar 18;19(5):1463-1471. doi: 10.5114/aoms/134059. eCollection 2023. Arch Med Sci. 2021. PMID: 37732031 Free PMC article.
-
Antifungal potentiality of mycogenic silver nanoparticles capped with chitosan produced by endophytic Amesia atrobrunnea.Saudi J Biol Sci. 2023 Sep;30(9):103746. doi: 10.1016/j.sjbs.2023.103746. Epub 2023 Aug 5. Saudi J Biol Sci. 2023. PMID: 37645687 Free PMC article.
-
Biosynthesized Silver Nanoparticles Derived from Probiotic Lactobacillus rhamnosus (AgNPs-LR) Targeting Biofilm Formation and Quorum Sensing-Mediated Virulence Factors.Antibiotics (Basel). 2023 May 31;12(6):986. doi: 10.3390/antibiotics12060986. Antibiotics (Basel). 2023. PMID: 37370305 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
